Trademark Overview
On Wednesday, November 20, 2024, a trademark application was filed for ONLEVAYT with the United States Patent and Trademark Office. The USPTO has given the ONLEVAYT trademark a serial number of 98862958. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 8, 2025. This trademark is owned by Corcept Therapeutics Incorporated. The ONLEVAYT trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders